Angiography Equipment Market Size, Share and Trends 2025 to 2034

Angiography Equipment Market Size and Forecast 2025 to 2034

The global angiography equipment market size was estimated at USD 11.12 billion in 2024 and is predicted to increase from USD 11.81 billion in 2025 to approximately USD 20.29 billion by 2034, expanding at a CAGR of 6.20% from 2025 to 2034. The growing application scope of angiography equipment is the key factor driving the market growth. Also, technological advancements coupled with the rising geriatric population are expected to fuel market growth shortly.

Angiography Equipment Market Key Takeaways

• North America dominated the angiography equipment market with the largest market share of 33% in 2024.
• Asia Pacific is expected to grow at the fastest CAGR of 6.5% over the projected period.
• By product, the angiography systems segment contributed the highest market share of 27% in 2024.
• By product, the contrast media segment is expected to grow at the fastest rate over the forecast period.
• By technology, the X-Ray segment held a major market share of 37% in 2024.
• By technology, the MRA segment is estimated to grow at the fastest rate during the forecast period.
• By procedure, the coronary segment accounted for the largest market share of 46% in 2024.
• By procedure, the endovascular segment is projected to grow at the fastest rate over the forecast period 
• By application, the diagnostic segment captured more than 60% of the market share in 2024.
• By application, the therapeutic segment is expected to grow at the fastest pace during the projected period.

The Role of Artificial Intelligence (AI) in Cardiovascular Imaging

The use of Artificial Intelligence in cardiovascular imaging fills the gap between big data, new technology, and the clinical provider. Machine learning (ML) algorithms can analyze a large amount of data sets via different approaches in the angiography equipment market. Furthermore, ML can automate some measurements in many imaging modalities. The surging use of AI in the market will optimize the development of precision medicine.

• In April 2024, Exo®, a medical imaging software and devices company, announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications now available on Exo Iris™, Exo's high-performance, handheld ultrasound device.

U.S. Angiography Equipment Market Size and Growth 2025 to 2034

The U.S. angiography equipment market size was exhibited at USD 3.08 billion in 2024 and is projected to be worth around USD 5.74 billion by 2034, growing at a CAGR of 6.42% from 2025 to 2034.

North America dominated the angiography equipment market in 2023. The dominance of the region can be attributed to the high healthcare expenditures, innovative healthcare infrastructure, and established presence of top pharmaceutical companies and manufacturers of medical devices. Moreover, the region has an escalating geriatric population that is prone to various chronic disorders, including cardiovascular diseases (CVDs), which can drive the demand for advanced diagnostic and monitoring systems.

• In April 2023, Caristo Diagnostics Limited, a world leader in cardiac and vascular disease diagnostics and risk assessment, completed its Series A financing round with an additional USD 16.3 million raised.

Caristo aims to use the funds to develop its CaRi-Heart technology. Asia Pacific is expected to grow at the fastest rate over the projected period. The growth of the region can be credited to the rapid growth of the region in the healthcare sector fuelled by advanced healthcare infrastructure, a large population pool, and rising healthcare expenditure. The surge in the incidence of chronic diseases, along with the increasing middle-class population, particularly in emerging economies such as China, Japan, and India, can propel angiography equipment market growth further.

Market Overview

Angiography equipment is an essential component in advanced diagnostic imaging because it enables physicians to look inside the organs and blood arteries to diagnose and manage various medical disorders. This device utilizes imaging techniques like magnetic resonance imaging (MRI), X-rays, and computed tomography (CT) to craft keen images of the heart, blood arteries, and other internal organs. These imaging methods are important for identifying and treating cardiovascular diseases like aneurysms, coronary artery disease (CAD), and peripheral artery disease (PAD).

Top 5 Medical Device Companies with Revenue Share (2023)

Angiography Equipment Market Growth Factors

• The increasing incorporation of advanced imaging technologies, such as hybrid modalities and 3D imaging, is expected to boost the market growth soon.
• The escalating incidences of cardiovascular diseases (CVD) are a significant factor propelling market growth soon.
• The ongoing emergence of minimally invasive techniques will likely contribute to the angiography equipment market expansion further.

Market Scope

Market Dynamics

Drivers

Increasing demand for interventional angiography systems

Minimal-invasive surgeries are cost-effective and rapid as compared to traditional surgery. The minimally invasive surgical processes raise the patient's safety, ensuring faster recovery by decreasing hospital stays, which fuels the market growth. In addition, in the current scenario, medical operators are increasingly adopting invasive surgical procedures over traditional open procedures because of their clinical benefits and cheapness.

• In February 2024, Philips Healthcare announced the launch of a limited release of a new light-based catheter guidance system for cath labs that represents a step toward radiation-free interventional imaging. The focus of the technology right now is endovascular aortic procedures.

Restraint

Technological complexities

The innovative nature of today's angiography technology complicates maintenance and operation. End-use systems use cutting-edge imaging technologies, including real-time image processing and 3D imaging, which necessitates specialized abilities and knowledge to perform well. However, due to technological complexity, healthcare professionals, particularly technicians, and radiologists, should receive proper training to ensure précised imaging.

Opportunity

Minimization of radiation exposures

There is an increasing emphasis on complying with Federal regulations for radiation exposure by market players. Players in the angiography equipment market are creating a system that reduces ionizing radiation by improving image quality. This is done through the application of innovative dose modulation techniques and image processing algorithms. Furthermore, interventional cardiologists depend highly on this equipment to offer precise diagnoses and advanced treatments for the elderly population.

• In September 2022, Royal Philips, a world leader in health technology, announced new milestones in the development of the world's first spectral detector angio CT solution, Philips Spectral Angio CT suite, bringing the company's breakthrough spectral CT imaging technology into an integrated hybrid angio CT suite.

Product Insights

The angiography systems segment dominated the angiography equipment market in 2024. The dominance of the segment can be attributed to technological advancements, frequent investments, and increasing scope of applications. Basically, there are four types of angiography systems: coronary angiography, cerebral angiography, pulmonary angiography, and renal angiography. These systems advance from catheter-based procedures to digitalized procedures.

• In June 2022, Shimadzu Medical Systems announced the launch of the New Angiography System. The new Trinias system uses AI deep learning technology to enhance the visibility of medical devices while using 40% or more lower*2 X-ray doses than previous models.

The contrast media segment is expected to grow at the fastest rate over the forecast period. The growth of the segment can be linked to the increasing utilization of these products in enhancing the visibility of blood vessels in various imaging techniques such as MRA, CT angiography, and X-ray. Additionally, they are also used in protectional fluoroscopy and radiography. The radiocontrast agents are barium sulfate,iodine and gadolinium.

Technology Insights

The X-ray segment led the global angiography equipment market in 2024. The dominance of the segment can be driven by high image resolution, efficient diagnosis process, and long-established use. X-ray angiography. This technology is extensively adopted as it offers detailed imaging which is necessary for precise intervention and diagnosis in surgeries such as stent placement and coronary angioplasty. Also, MRA, X-ray, and CT. market players are heavily investing in creating advanced technologies.

• In November 2024, Silveray, a company pioneering Digital X-ray Film (DXF) technology, raised £4M in a seed extension funding round led by Northern Gritstone, an investment firm that emphasizes science and technology ventures in the North of England. The funding will support Silveray's efforts to finalize the development of its first DXF product.

The MRA segment is estimated to grow at the fastest rate during the forecast period. The growth of the segment is due to the benefits of minimal exposure to harmful radiation when diagnosing heart disease.MRA gives 3D capabilities to get images of any anatomical part with exceptional soft tissue contrast. Moreover, the launch of 3.0T MR imaging has substantially improved the diagnosis of CVD disorders.

Procedure Insights

In 2024, the coronary segment held the largest angiography equipment market share. The dominance and growth of the segment are because of the rising prevalence of coronary artery disease (CAD) in developing nations such as China and India. Coronary angiography is important for diagnosing and assessing coronary artery disorders and treatment strategies, including bypass surgery or stenting. Developments in imaging methods, like the shift from single slice to multislice Computed Tomography, have substantially enhanced the diagnostic capabilities.

The endovascular segment is projected to grow at the fastest rate over the forecast period. Endovascular procedures, such as stent placements, angioplasties, and embolization techniques, are increasingly used to treat vascular conditions like aneurysms, peripheral artery disease, and deep vein thrombosis. Also, increasing preference for minimally invasive procedures that offer reduced recovery times, lower risk of complications, and improved patient outcomes.

Application Insights

The diagnostic segment dominated the angiography equipment market in 2024. The dominance and growth of the segment can be credited to the ongoing developments in MRA and CTA to offer appropriate data in neurology and cardiology, such as brain arteriovenous malformation, cerebral aneurysms, dural arteriovenous fistula, and occlusive diseases. Furthermore, the increasing awareness of (CVDs) and the risk factors associated with them is anticipated to propel market growth. Diagnostic angiography is essential for early detection of disease and treatment planning that, raises its need across diagnostic centers and hospitals.

• In February 2024, Royal Philips, a world leader in health technology, announced the launch of its new Azurion neuro biplane system. Created to enhance productivity and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system consists of improved 2D and 3D imaging and X-ray detector positioning flexibility.

The therapeutic segment is expected to grow at the fastest pace during the projected period. This segment includes targeted therapies for cancer, cardiovascular disorders, and neurological diseases. Its growth can be attributed to the growing demand for advanced treatments across various medical conditions. Additionally, the increase in chronic conditions, aging populations, and the demand for personalized treatments have driven the growth of this segment, making it a primary focus for medical advancements and investments.

Angiography Equipment Market Companies

• Medtronic plc
• Boston Scientific Corporation
• Angiodynamics, Inc.
• Abbott
• Microport Scientific Corporation
• B. BRAUN SE
• KONINKLIJKE PHILIPS N.V.
• GE Healthcare
• Cardinal Health
• Siemens Healthineers AG
• SHIMADZU CORPORATION

Latest Announcement by Market Players

• In May 2024, Medtronic plc announced the appointment of Mandeep Singh Kumar as the new vice president and managing director of the company, effective May 2024. He replaces Michael Blackwell, who has returned to the United States to pursue new opportunities.
• In March 2024, Wipro GE Healthcare announced an investment of over INR 8,000 crore in manufacturing and local R&D in India over the next five years.GE HealthCare president & CEO Peter J Arduini, who was in India to make the announcement, noted that this investment is on top of the USD 4 billion that the company has made since its establishment in 1990.

Recent Developments

• In October 2024, Shimadzu Corporation launched SMART Voice, a voice recognition feature for its Trinias angiography systems, aimed at improving efficiency and reducing the workload for healthcare professionals.
• In June 2024, NIDEK CO., LTD. introduced the RS-1 Glauvas Optical Coherence Tomography (OCT). This system features a scanning speed of up to 250 kHz, enabling fast and accurate imaging. It is designed to enhance workflow efficiency and diagnostic confidence for glaucoma and retinal vascular diseases. 
• In August 2023, Canon Medical, a medical equipment firm, will sell its Alphenix/Evolve Edition angiography system in the European market. The device uses real-time deep learning technology to enhance imaging and reduce radiation dose during percutaneous coronary intervention and structural heart disease operations.

Segments Covered in the Report

By Product

• Angiography Systems
• Catheters
• Guidewire
• Balloons
• Contrast Media
• Vascular Closure Devices
• Angiography Accessories

By Technology

• X-Ray
• MRI
• CT

By Procedure

• Coronary
• Endovascular
• Neurovascular

By Application

• Diagnostic
• Therapeutic

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa